These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 33419872)

  • 1. Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV.
    Nunes MC; Cutland CL; Klugman KP; Madhi SA
    mBio; 2021 Jan; 12(1):. PubMed ID: 33419872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Streptococcus pneumoniae in hospitalization for acute community-acquired pneumonia associated with culture-confirmed Mycobacterium tuberculosis in children: a pneumococcal conjugate vaccine probe study.
    Moore DP; Klugman KP; Madhi SA
    Pediatr Infect Dis J; 2010 Dec; 29(12):1099-04. PubMed ID: 21155174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of invasive bacterial infections in pneumococcal conjugate vaccine-vaccinated and -unvaccinated children under 5 years of age in Soweto, South Africa: a cohort study from a high-HIV burden setting.
    Johnstone SL; Moore DP; Klugman KP; Madhi SA; Groome MJ
    Paediatr Int Child Health; 2020 Feb; 40(1):50-57. PubMed ID: 31156062
    [No Abstract]   [Full Text] [Related]  

  • 4. A trial of a 7-valent pneumococcal conjugate vaccine in HIV-infected adults.
    French N; Gordon SB; Mwalukomo T; White SA; Mwafulirwa G; Longwe H; Mwaiponya M; Zijlstra EE; Molyneux ME; Gilks CF
    N Engl J Med; 2010 Mar; 362(9):812-22. PubMed ID: 20200385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indirect Effects of 10-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumococcal Pneumonia in Rural Western Kenya.
    Bigogo GM; Audi A; Auko J; Aol GO; Ochieng BJ; Odiembo H; Odoyo A; Widdowson MA; Onyango C; Borgdorff MW; Feikin DR; Carvalho MDG; Whitney CG; Verani JR
    Clin Infect Dis; 2019 Nov; 69(12):2177-2184. PubMed ID: 30785189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyomaviruses-associated respiratory infections in HIV-infected and HIV-uninfected children.
    Nunes MC; Kuschner Z; Rabede Z; Cutland CL; Madimabe R; Kuwanda L; Klugman KP; Adrian PV; Madhi SA
    J Clin Virol; 2014 Dec; 61(4):571-8. PubMed ID: 25467863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccine--a health priority.
    Zar HJ; Madhi SA
    S Afr Med J; 2008 Jun; 98(6):463-7. PubMed ID: 18683380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumonia hospitalizations of children aged <2 years in Poland before (2013-2016) and after (2017-2018) universal mass vaccination with 10-valent pneumococcal non-typeable
    Bhavsar A; Zaryczański J; Wasilewska A; Saragoussi D; Devadiga R; Colby C; Bahar E; Wysocki J
    Hum Vaccin Immunother; 2022 Nov; 18(6):2128566. PubMed ID: 36239615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
    Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
    Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study.
    Hammitt LL; Campbell JC; Borys D; Weatherholtz RC; Reid R; Goklish N; Moulton LH; Traskine M; Song Y; Swinnen K; Santosham M; O'Brien KL
    Vaccine; 2019 Dec; 37(51):7482-7492. PubMed ID: 31629570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumococcal nasopharyngeal carriage among Bhutanese children hospitalized with clinical pneumonia: serotypes and viral co-infection.
    Jullien S; Sharma R; Lhamu Mynak M; Henares D; Muñoz-Almagro C; Bassat Q
    BMC Infect Dis; 2020 Dec; 20(1):940. PubMed ID: 33297987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 13-valent pneumococcal conjugate vaccination of adults on lower respiratory tract infections and antibiotic use in primary care: secondary analysis of a double-blind randomized placebo-controlled study.
    van Werkhoven CH; Bolkenbaas M; Huijts SM; Verheij TJM; Bonten MJM
    Clin Microbiol Infect; 2021 Jul; 27(7):995-999. PubMed ID: 32971253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
    Cutts FT; Zaman SM; Enwere G; Jaffar S; Levine OS; Okoko JB; Oluwalana C; Vaughan A; Obaro SK; Leach A; McAdam KP; Biney E; Saaka M; Onwuchekwa U; Yallop F; Pierce NF; Greenwood BM; Adegbola RA;
    Lancet; 2005 Mar 26-Apr 1; 365(9465):1139-46. PubMed ID: 15794968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: Exploratory analysis of the CAPiTA trial.
    Huijts SM; Coenjaerts FEJ; Bolkenbaas M; van Werkhoven CH; Grobbee DE; Bonten MJM;
    Clin Microbiol Infect; 2018 Jul; 24(7):764-770. PubMed ID: 29050992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
    Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N;
    N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sinusitis and pneumonia hospitalization after introduction of pneumococcal conjugate vaccine.
    Lindstrand A; Bennet R; Galanis I; Blennow M; Ask LS; Dennison SH; Rinder MR; Eriksson M; Henriques-Normark B; Ortqvist A; Alfvén T
    Pediatrics; 2014 Dec; 134(6):e1528-36. PubMed ID: 25384486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.
    Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB
    Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection.
    Nachman S; Kim S; King J; Abrams EJ; Margolis D; Petru A; Shearer W; Smith E; Moye J; Blanchard S; Hawkins E; Bouquin P; Vink P; Benson M; Estep S; Malinoski F;
    Pediatrics; 2003 Jul; 112(1 Pt 1):66-73. PubMed ID: 12837869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines.
    Ajibola G; Bennett K; Powis KM; Hughes MD; Leidner J; Kgole S; Batlang O; Mmalane M; Makhema J; Lockman S; Shapiro R
    PLoS One; 2020; 15(12):e0244100. PubMed ID: 33347474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric hospitalization for pneumococcal diseases preventable by 7-valent pneumococcal conjugate vaccine in Hong Kong.
    Ho PL; Chiu SS; Chow FK; Mak GC; Lau YL
    Vaccine; 2007 Sep; 25(39-40):6837-41. PubMed ID: 17714837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.